company

MEDICOVER NORWAY AS

1366 LYSAKER

Return on Equity
−13,74 %
Current Ratio
0,21
Debt-to-Equity Ratio
3,87
Key figures (NOK)2022
Revenue0
Net Income−4 958 000
Total Assets186 234 000
Total Equity36 076 000
Income (NOK)2022
Revenue0
Expenditure191 000
Operating Profit−190 000
Financial Income4 154 000
Financial Costs8 922 000
Financial Balance−4 768 000
Earnings Before Tax−4 958 000
Tax0
Net Income−4 958 000
Balance (NOK)2022
Total Fixed Assets183 966 000
Total Current Assets2 268 000
Total Assets186 234 000
Total Retained Equity−9 104 000
Total Equity36 076 000
Total Long-Term Debt139 450 000
Total Current Debt10 707 000
Total Equity and Debt186 234 000
Cash flow (NOK)2022
Sales Income0
Other Income0
Revenue0
Cost of Goods Sold0
Salary Costs23 000
Depreciation0
Impairment0
Expenditure191 000
Operating Profit−190 000
Financial Income4 154 000
Financial Costs8 922 000
Financial Balance−4 768 000
Dividends0
Net Income−4 958 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets183 966 000
Total Fixed Assets183 966 000
Stock0
Total Investments0
Cash, Bank0
Total Current Assets2 268 000
Total Assets186 234 000
Total Equity36 076 000
Short-Term Group Debt0
Total Long-Term Debt139 450 000
Creditors4 000
Unpaid Taxes9 000
Dividends0
Other Current Debt10 694 000
Total Current Debt10 707 000
Total Equity and Debt186 234 000
Financial indicators2022
Return on Equity−13,74 %
Debt-to-Equity Ratio3,87
Operating Profit Margin-
Current Ratio0,21
Quick Ratio0,21
Equity Ratio0,19
Gross Profit Margin-
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English